BRIEF published on 02/17/2026 at 07:35, 16 days 9 hours ago Leadership Transition at Sensorion amid Strategic Focus on Hearing Loss Therapies Biotechnology Gene Therapy Leadership Change Sensorion Hearing Loss
BRIEF published on 02/17/2026 at 07:35, 16 days 9 hours ago Sensorion announces changes in its management Change Of Direction Sensory Auditory Therapy Sanofi Financing Medical Pipeline
PRESS RELEASE published on 02/17/2026 at 07:30, 16 days 9 hours ago Inside Information / Other news releases Sensorion announces Nawal Ouzren stepping down as CEO for personal reasons. Amit Munshi to serve as Interim CEO. Sanofi-led financing for pipeline assets Leadership Changes Sanofi Sensorion Amit Munshi Nawal Ouzren
BRIEF published on 02/06/2026 at 07:35, 27 days 9 hours ago Sensorion to Participate in ARO 49th Annual Midwinter Meeting Biotechnology Gene Therapy Sensorion Hearing Loss ARO Meeting
PRESS RELEASE published on 02/06/2026 at 07:30, 27 days 9 hours ago Inside Information / Other news releases Sensorion to present SENS-601 gene therapy at ARO 49th Annual Midwinter Meeting in Puerto Rico Gene Therapy Sensorion Hearing Loss SENS-601 ARO 49th Annual Midwinter Meeting
BRIEF published on 01/28/2026 at 07:48, 1 month 8 days ago Sensorion Secures €60 Million Financing to Advance Hearing Loss Therapies Gene Therapy Biotech Financing Sensorion Hearing Loss Sanofi Investment
PRESS RELEASE published on 01/28/2026 at 07:43, 1 month 8 days ago Inside Information / Other news releases Sensorion announces €60 million financing with a €20M strategic investment from Sanofi and support from global healthcare specialists to advance genetic medicine pipeline. Cash runway extended until H1 2027 Financing Sanofi Sensorion Genetic Medicine Healthcare Specialists
BRIEF published on 12/19/2025 at 07:35, 2 months 17 days ago Sensorion to Present at J.P. Morgan Healthcare Conference Biotechnology Gene Therapy J.P. Morgan Hearing Loss SENS-401
PRESS RELEASE published on 12/19/2025 at 07:30, 2 months 17 days ago Inside Information / Other news releases Sensorion to present at 44th Annual J.P. Morgan Healthcare Conference with focus on novel therapies for hearing loss disorders. CEO Nawal Ouzren to lead presentation Biotechnology Sensorion Hearing Loss Disorders J.P. Morgan Healthcare Conference Thérapies
BRIEF published on 09/17/2025 at 07:35, 5 months 18 days ago Sensorion announces its 2025 half-year results Funding Gene Therapy SENS-401 SENS-501 2025 Results
Published on 03/05/2026 at 14:00, 3 hours 25 minutes ago EQ Inc. Secures Strategic Partnership with Global Card Network to Expand Integrated Rewards Across Canada
Published on 03/05/2026 at 14:00, 3 hours 25 minutes ago GameSquare's Stream Hatchet Publishes 2025 YouTube Gaming Trends Report
Published on 03/05/2026 at 14:00, 3 hours 25 minutes ago Horizon Aircraft's Unique VTOL Delivers Up to 75% Lower Operating Costs Than Helicopters
Published on 03/05/2026 at 13:40, 3 hours 45 minutes ago Lobe Sciences Ltd. Announces Presence in Miami During the Jefferies and Leerink Healthcare Conferences
Published on 03/05/2026 at 13:30, 3 hours 55 minutes ago Vox Royalty Provides 2026 Guidance and Increases Quarterly Dividend
Published on 03/05/2026 at 17:04, 20 minutes ago Inclusion in the SDAX confirms Einhell's consistent growth trajectory
Published on 03/05/2026 at 16:55, 29 minutes ago Viettel Solutions and Aduna Global Sign Network API Partnership at MWC 2026
Published on 03/05/2026 at 16:45, 39 minutes ago GSMA MWC26 Barcelona closes 20ᵗʰ anniversary edition
Published on 03/04/2026 at 23:50, 17 hours 35 minutes ago Total number of voting rights and shares making up the share capital at February 28, 2026
Published on 03/04/2026 at 18:00, 23 hours 24 minutes ago Disclosure of Share Capital and Voting Rights as of February 28, 2026
Published on 03/04/2026 at 17:45, 23 hours 40 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
